Lupin launches Generic Suprep Bowel Prep Kit in US

9 Sep 2022 , 03:15 PM

Lupin Limited has announced the launch of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, having received an approval from the United States Food and Drug Administration (USFDA).

As per the pregulatory filing, Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces is a generic equivalent of Suprep Bowel Prep Kit Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, of Braintree Laboratories Inc.

According to the IQVIA MAT July 2022, Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution (RLD Suprep Bowel Prep Kit) had estimated annual sales of USD 202 million in the U.S.

At around 3:15 PM, Lupin Ltd is currently trading at Rs669.80 per share up by Rs3.05 or 0.46% from its previous closing of Rs666.75 per share on the BSE.

For feedback and suggestions, write to us at [e-mail]